These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 28923857)
1. MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway. Yu T; Zhao Y; Hu Z; Li J; Chu D; Zhang J; Li Z; Chen B; Zhang X; Pan H; Li S; Lin H; Liu L; Yan M; He X; Yao M Cancer Res; 2017 Nov; 77(21):5782-5794. PubMed ID: 28923857 [TBL] [Abstract][Full Text] [Related]
2. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Tang Y; Xiao G; Chen Y; Deng Y Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897 [TBL] [Abstract][Full Text] [Related]
3. Rab11-FIP2 suppressed tumor growth via regulation of PGK1 ubiquitination in non-small cell lung cancer. Dong W; Li H; Wu X Biochem Biophys Res Commun; 2019 Jan; 508(1):60-65. PubMed ID: 30471866 [TBL] [Abstract][Full Text] [Related]
4. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer. Li J; Cheng D; Zhu M; Yu H; Pan Z; Liu L; Geng Q; Pan H; Yan M; Yao M Theranostics; 2019; 9(1):179-195. PubMed ID: 30662561 [TBL] [Abstract][Full Text] [Related]
5. ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer. Zhang P; Yu S; Li H; Liu C; Li J; Lin W; Gao A; Wang L; Gao W; Sun Y FEBS Lett; 2015 Aug; 589(17):2248-56. PubMed ID: 26149216 [TBL] [Abstract][Full Text] [Related]
6. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway. Yu SH; Zhang CL; Dong FS; Zhang YM J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230 [TBL] [Abstract][Full Text] [Related]
7. NEAT1 mediates paclitaxel-resistance of non-small cell of lung cancer through activation of Akt/mTOR signalling pathway. Li B; Gu W; Zhu X J Drug Target; 2019 Dec; 27(10):1061-1067. PubMed ID: 30782035 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
10. ROR1-AS1 knockdown inhibits growth and invasion and promotes apoptosis in NSCLC cells by suppression of the PI3K/Akt/mTOR pathway. Li F; Gu F; Li Q; Zhai C; Gong R; Zhu X J Biochem Mol Toxicol; 2021 May; 35(5):e22726. PubMed ID: 33491326 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer. Lu J; Zang H; Zheng H; Zhan Y; Yang Y; Zhang Y; Liu S; Feng J; Wen Q; Long M; Fan S PLoS One; 2020; 15(2):e0227768. PubMed ID: 32023262 [TBL] [Abstract][Full Text] [Related]
12. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway. Xing Y; Meng Q; Chen X; Zhao Y; Liu W; Hu J; Xue F; Wang X; Cai L Oncotarget; 2016 May; 7(21):30479-91. PubMed ID: 27058415 [TBL] [Abstract][Full Text] [Related]
13. Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway. Zhuo Y; Li S; Hu W; Zhang Y; Shi Y; Zhang F; Zhang J; Wang J; Liao M; Chen J; Qian H; Li D; Sun C J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35577506 [TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer. Pan C; Yao G; Liu B; Ma T; Xia Y; Wei K; Wang J; Xu J; Chen L; Chen Y Cell Physiol Biochem; 2017; 43(1):339-352. PubMed ID: 28854421 [TBL] [Abstract][Full Text] [Related]
15. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas. Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950 [TBL] [Abstract][Full Text] [Related]
16. MetaLnc9-Antisense RNA Contributes to Lung Cancer Metastasis via Modulating RNA-RNA Duplex with MetaLnc9. Yu T; Lin K; Pan H; Sun L; Zhu Y DNA Cell Biol; 2022 Apr; 41(4):390-399. PubMed ID: 35333617 [TBL] [Abstract][Full Text] [Related]
17. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related]
18. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672 [TBL] [Abstract][Full Text] [Related]
19. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway. Jiang W; Kai J; Li D; Wei Z; Wang Y; Wang W J Cell Physiol; 2020 Oct; 235(10):7194-7203. PubMed ID: 32039488 [TBL] [Abstract][Full Text] [Related]
20. cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth. Chen Z; Li JL; Lin S; Cao C; Gimbrone NT; Yang R; Fu DA; Carper MB; Haura EB; Schabath MB; Lu J; Amelio AL; Cress WD; Kaye FJ; Wu L J Clin Invest; 2016 Jun; 126(6):2267-79. PubMed ID: 27140397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]